Product image of Inizol (Pantoprazole Sodium Sesquihydrate) supplied by GNH India

Inizol

Active Ingredient:
Pantoprazole Sodium Sesquihydrate
Origin:
EU

Inizol (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Inizol, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as GERD, erosive oesophagitis and Zollinger‑Ellison syndrome.

GNH India supplies Inizol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

S.F. Group Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Inizol (pantoprazole) is employed to manage conditions within the acid‑related disorder pathway.

  • Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and relieves heartburn and regurgitation.
  • Erosive oesophagitis: promotes healing of inflamed esophageal tissue.
  • Zollinger‑Ellison syndrome: controls excessive gastric acid production.
  • Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients taking NSAIDs.
  • Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance when used with antibiotics.

How It Works

  • Pantoprazole sodium sesquihydrate irreversibly binds to the H+/K+ ATPase enzyme (gastric proton pump) on the secretory surface of parietal cells, blocking the final step of acid secretion. This inhibition markedly reduces both basal and stimulated gastric acid output, facilitating symptom relief and mucosal healing in acid‑related conditions.

Side Effects

Common Side Effects

  • Headache
  • Diarrhea
  • Abdominal pain
  • Nausea
  • Flatulence
  • Constipation

Serious or Rare Side Effects

  • Anaphylaxis or severe allergic reactions
  • Clostridioides difficile‑associated diarrhea
  • Stevens‑Johnson syndrome or toxic epidermal necrolysis
  • Elevated liver enzymes
  • Hypomagnesemia (low magnesium levels)
  • Acute pancreatitis

Precautions & Warnings

Before initiating therapy, consider the following precautions:

  • Assess renal function: dose adjustment may be needed in severe impairment.
  • Monitor for Clostridioides difficile infection: especially in hospitalized patients.
  • Use caution in elderly patients: increased susceptibility to electrolyte disturbances.
  • Avoid abrupt discontinuation: may cause rebound acid hypersecretion.
  • Review concomitant medications that affect gastric pH or metabolism.
  • Store at room temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Pantoprazole may interact with several drugs; awareness of interaction severity is essential.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect.
  • Atazanavir: decreased absorption and efficacy.
  • HIV protease inhibitors (e.g., ritonavir): altered plasma levels.
  • Methotrexate: reduced renal clearance.
  • Warfarin: variable INR changes.

Moderate Interactions (Monitor Closely)

  • Digoxin: increased serum concentration.
  • Phenytoin: decreased plasma levels.
  • Carbamazepine: reduced effectiveness.
  • Fluconazole: increased pantoprazole exposure.
  • Ketoconazole: elevated ketoconazole levels.

Frequently Asked Questions

Inizol contains pantoprazole sodium sesquihydrate, a proton pump inhibitor indicated for the management of acid‑related disorders such as gastro‑oesophageal reflux disease, erosive oesophagitis, Zollinger‑Ellison syndrome, prevention of NSAID‑induced gastric ulcers, and as part of combination therapy for Helicobacter pylori eradication.

Pantoprazole irreversibly binds to the H+/K+ ATPase enzyme (the gastric proton pump) on parietal cells, blocking the final step of acid production. This inhibition markedly lowers both basal and stimulated gastric acid output, providing symptom relief and allowing mucosal healing.

The dosage of Inizol is individualized by the prescribing healthcare professional based on the specific indication, disease severity, and patient characteristics. The prescriber determines the appropriate strength, frequency, and duration, and patients should follow the written prescription without alteration.

Safety data for pantoprazole during pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider. Breastfeeding mothers should consult their physician before use.

To place an order, submit an enquiry on the Inizol product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Inizol (pantoprazole) shares the same class mechanism as omeprazole, esomeprazole, lansoprazole and rabeprazole, but differs in its pharmacokinetic profile and interaction potential. Pantoprazole is less dependent on CYP2C19 metabolism, which may reduce certain drug‑drug interactions, making it a preferred option when a lower interaction risk is desired.

Inizol tablets should be stored at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in humid areas such as bathrooms. No refrigeration is required.

Inizol is taken orally, usually with a glass of water. It may be taken with or without food, but consistency regarding meals is recommended to maintain stable absorption. Swallow the tablet whole; do not crush, chew, or split unless specifically instructed by a healthcare professional.

Serious adverse events, although rare, can include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, liver enzyme elevations, hypomagnesemia, and acute pancreatitis. Seek immediate medical attention if you experience rash, persistent diarrhea, abdominal pain, muscle cramps, or signs of infection.

Inizol is contraindicated in patients with known hypersensitivity to pantoprazole or any component of the formulation. Caution is advised for individuals with severe hepatic impairment, those on medications with major interactions such as clopidogrel, and patients with a history of C. difficile infection. A healthcare professional should evaluate suitability before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.